Cross Staff Investments’s Johnson & Johnson JNJ Stock Holding History

Cross Staff Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39M	Sell	5,477 -846	-13%	-$197K	0.78%	32
2026 Q1	$1.55M	Sell	6,323 -534	-8%	-$124K	0.78%	25
2025 Q4	$1.42M	Hold	6,857	–	–	0.78%	29
2025 Q3	$1.27M	Hold	6,857	–	–	0.89%	31
2025 Q2	$1.05M	Sell	6,857 -25	-0.4%	-$3.84K	0.78%	37
2025 Q1	$1.14M	Buy	6,882 +22	+0.3%	+$3.44K	0.86%	35
2024 Q4	$992K	Sell	6,860 -50	-0.7%	-$7.75K	0.69%	38
2024 Q3	$1.12M	Buy	6,910 +59	+0.9%	+$9.4K	0.86%	36
2024 Q2	$1M	Hold	6,851	–	–	0.83%	34
2024 Q1	$1.08M	Hold	6,851	–	–	0.91%	33
2023 Q4	$1.07M	Buy	6,851 +250	+4%	+$38.3K	0.95%	26
2023 Q3	$1.03M	Sell	6,601 -509	-7%	-$84K	1.01%	26
2023 Q2	$1.18M	Hold	7,110	–	–	1.08%	23
2023 Q1	$1.1M	Hold	7,110	–	–	1.09%	25
2022 Q4	$1.26M	Buy	7,110 +60	+0.9%	+$10.4K	1.32%	20
2022 Q3	$1.15M	Hold	7,050	–	–	1.29%	17
2022 Q2	$1.25M	Hold	7,050	–	–	1.38%	16
2022 Q1	$1.25M	Sell	7,050 -784	-10%	-$133K	1.16%	20
2021 Q4	$1.34M	Buy	+7,834	New	+$1.28M	1.2%	21

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cross Staff Investments's JNJ Position: Q2 2026 in Review

Cross Staff Investments reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $197K and leaving 5,477 shares worth $1.39M. The position accounts for 0.78% of the portfolio, ranked #32.

Cross Staff Investments first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.55M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Cross Staff Investments held 5,477 shares of Johnson & Johnson worth $1.39M as of Q2 2026.
Cross Staff Investments sold 846 Johnson & Johnson shares in Q2 2026, an estimated $197K.
Johnson & Johnson made up 0.78% of Cross Staff Investments's portfolio in Q2 2026, its #32 holding.
Cross Staff Investments first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
Cross Staff Investments's Johnson & Johnson position peaked at $1.55M in Q1 2026.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.